Journal Scans
Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines
Guidelines for Follow-up of Patients With Stage III Melanoma
E Romano, M Scordo, SW Dusza, DG Coit, PB Chapman
20100520
2010 Jun 20
J Clin Oncol
Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines
J Clin Oncol. 2010 Jun 20;28(18):3042-3047, E Romano, M Scordo, SW Dusza, DG Coit, PB Chapman
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
The risk of relapse in patients with resectable stage III melanoma varies according to the substage, as defined by the American Joint Committee on Cancer (AJCC). Evidence-based strategies for follow-up to detect early relapse are lacking, however. National Comprehensive Cancer Network guidelines are based more on anecdotal evidence than on data and do not take AJCC substage into account. In this retrospective analysis by Romano et al, investigators used data from the Memorial Sloan-Kettering Cancer...
